A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults
Title:
A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults
Author:
Talaat, Kawsar R. Karron, Ruth A. Callahan, Karen A. Luke, Catherine J. DiLorenzo, Susan C. Chen, Grace L. Lamirande, Elaine W. Jin, Hong Coelingh, Kathy L. Murphy, Brian R. Kemble, George Subbarao, Kanta